Pages that link to "Q34301553"
Jump to navigation
Jump to search
The following pages link to Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. (Q34301553):
Displaying 50 items.
- Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia (Q21194921) (← links)
- Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature (Q21195047) (← links)
- Lung microbiology and exacerbations in COPD (Q22305860) (← links)
- Interventions to improve antibiotic prescribing practices for hospital inpatients (Q24197807) (← links)
- Antibiotics for acute bronchitis (Q24198126) (← links)
- De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock (Q24198268) (← links)
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections (Q24200676) (← links)
- De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock (Q24235566) (← links)
- Procalcitonin to initiate or withhold antibiotics in acute respiratory tract infections (Q24241768) (← links)
- Antibiotics for acute bronchitis (Q24245925) (← links)
- Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia (Q24794396) (← links)
- Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. (Q24802551) (← links)
- Procalcitonin testing has the potential to reduce unnecessary antibiotic use in patients with suspected lower respiratory tract infections (Q24811639) (← links)
- (Q24815302) (← links)
- Procalcitonin to guide antibiotic therapy in the ICU (Q26775450) (← links)
- Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis (Q26777020) (← links)
- Sepsis: From Pathophysiology to Individualized Patient Care (Q26799911) (← links)
- Viral-bacterial interactions-therapeutic implications (Q26825261) (← links)
- Duration of antimicrobial therapy in community acquired pneumonia: less is more (Q26828493) (← links)
- Cardiac biomarkers: new tools for heart failure management (Q26991726) (← links)
- Community-acquired pneumonia: identification and evaluation of nonresponders (Q27002420) (← links)
- Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections (Q27023057) (← links)
- State of the Art: Newer biomarkers in heart failure (Q27027899) (← links)
- Perspective on optimizing clinical trials in critical care: how to puzzle out recurrent failures (Q28069198) (← links)
- Evidence-based acute bronchitis therapy (Q28277334) (← links)
- Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation (Q28660920) (← links)
- Host-Based Peripheral Blood Gene Expression Analysis for Diagnosis of Infectious Diseases (Q30243921) (← links)
- Procalcitonin for clinical decisions on influenza-like illness in emergency department during influenza a(H1N1)2009 pandemic (Q30396773) (← links)
- New challenges in community-acquired pneumonia (Q30399618) (← links)
- Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia (Q30403782) (← links)
- Revolutionizing clinical microbiology laboratory organization in hospitals with in situ point-of-care (Q31029164) (← links)
- Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia (Q33276665) (← links)
- Community-acquired respiratory infections in non-immunocompromised adults (Q33281471) (← links)
- Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial (Q33290142) (← links)
- Procalcitonin in liver transplantation: are high levels due to donors or recipients? (Q33349213) (← links)
- The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin leve (Q33351100) (← links)
- Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study (Q33378956) (← links)
- Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department (Q33400876) (← links)
- Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study (Q33505806) (← links)
- Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay (Q33520362) (← links)
- Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score (Q33539217) (← links)
- Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives (Q33540012) (← links)
- Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study (Q33557838) (← links)
- Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial (Q33584747) (← links)
- Serial Procalcitonin as a Predictor of Bacteremia and Need for Intensive Care Unit Care in Adults With Pneumonia, Including Those With Highest Severity: A Prospective Cohort Study (Q33629533) (← links)
- Using Procalcitonin to Guide Antibiotic Therapy (Q33629591) (← links)
- Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia (Q33714041) (← links)
- Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: a multicenter analysis of 4,698 cases (Q33750355) (← links)
- Monitoring treatment response in abdominal sepsis with procalcitonin--if only! (Q33752801) (← links)
- Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients (Q33754533) (← links)